Search
Oncology Institute Inc
TOIAdd to Watchlist
5.280USD
-0.230-4.17%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
522.00MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-4.17%
5 Days
-2.04%
1 Month
+11.39%
6 Months
+43.87%
Year to Date
+48.31%
1 Year
+109.52%
Key Figures
5.540Open
5.560High
1.28MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.30%Turnover Ratio
5.510Prev. Close
5.190Low
4.81MTurnover
LossP/E Static
-33.21P/B
0.00%Div Yield TTM
-26.19%ROA
4.88052wk High
0.83Volume Ratio
-53.01MNet Profit
98.86MShares
-0.3566EPS TTM
0.39Beta
-3410.47%ROE
2.01552wk Low
6.72%Amplitude
14.72%Gross Margin
522.00MMarket Cap
3.33Reward/Risk
4.88%Risk Rate
TradingKey Stock Score of Oncology Institute Inc
Currency: USD Updated: 2026-07-02Key Insights
Oncology Institute Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 43 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.75.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Oncology Institute Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Oncology Institute Inc Highlights
StrengthsRisks
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 55.05% year-on-year.
Undervalued
The company’s latest PE is -14.81, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 47.47M shares, decreasing 17.60% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 2.44K shares of this stock.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
7.750
Target Price
+40.65%
Upside Space
Oncology Institute Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Oncology Institute Inc Info
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Ticker SymbolTOI
CompanyOncology Institute Inc
CEOVirnich (Daniel)
Websitehttps://theoncologyinstitute.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Oncology Institute Inc (TOI)?
The current price of Oncology Institute Inc (TOI) is 5.28.
What is the symbol of Oncology Institute Inc?
The ticker symbol of Oncology Institute Inc is TOI.
What is the 52-week high of Oncology Institute Inc?
The 52-week high of Oncology Institute Inc is 4.88.
What is the 52-week low of Oncology Institute Inc?
The 52-week low of Oncology Institute Inc is 2.02.
What is the market capitalization of Oncology Institute Inc?
The market capitalization of Oncology Institute Inc is 522.00M.
Is Oncology Institute Inc (TOI) currently rated as Buy, Hold, or Sell?
According to analysts, Oncology Institute Inc (TOI) has an overall rating of Buy, with a price target of 7.75.
What is the Earnings Per Share (EPS TTM) of Oncology Institute Inc (TOI)?
The Earnings Per Share (EPS TTM) of Oncology Institute Inc (TOI) is -0.54.